Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs

References

• De JongWHBormPJDrug delivery and nanoparticles: applications and hazardsInt J Nanomedicine20083213314918686775
   PubMed Web of Science ®Google Scholar
• FarokhzadOCLangerRImpact of nanotechnology on drug deliveryACS Nano200931162019206243
   PubMed Web of Science ®Google Scholar
• KippJEThe role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugsInt J Pharm20042841–210912215454302
   PubMedGoogle Scholar
• HuJJohnstonKPWilliamsRO3rdNanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugsDrug Dev Ind Pharm200430323324515109023
   PubMed Web of Science ®Google Scholar
• LeeSJKimYHLeeSHHahnMCharacterization of nano oxaliplatin prepared by novel Fat Employing Supercritical Nano System, the FESNS(R)Pharm Dev Technol201217221221821073400
   PubMed Web of Science ®Google Scholar
• ZhaoMSuMLinXEvaluation of docetaxel-loaded intravenous lipid emulsion: pharmacokinetics, tissue distribution, antitumor activity, safety and toxicityPharm Res20102781687170220552255
   PubMed Web of Science ®Google Scholar
• FauzeeNJTaxanes: promising anti-cancer drugsAsian Pac J Cancer Prev201112483785121790213
   PubMedGoogle Scholar
• ClarkeSJRivoryLPClinical pharmacokinetics of docetaxelClin Pharmacokinet19993629911410092957
   PubMed Web of Science ®Google Scholar
• VerweijJClavelMChevalierBPaclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kindAnn Oncol1994564955057918121
   PubMed Web of Science ®Google Scholar
• NelAXiaTMadlerLLiNToxic potential of materials at the nanolevelScience2006311576162262716456071
   PubMed Web of Science ®Google Scholar
• FanAMAlexeeffGNanotechnology and nanomaterials: toxicology, risk assessment, and regulationsJ Nanosci Nanotechnol201010128646865721121378
   PubMed Web of Science ®Google Scholar
• LinkovISatterstromFKCoreyLMNanotoxicology and nanomedicine: making hard decisionsNanomedicine20084216717118329962
   PubMed Web of Science ®Google Scholar
• WangYChenLTanLPEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapyBiomaterials201435256972698524836952
   PubMed Web of Science ®Google Scholar
• WangYWangCGongCPolysorbate 80 coated poly (varepsilon-caprolactone)-poly (ethylene glycol)-poly (varepsilon-caprolactone) micelles for paclitaxel deliveryInt J Pharm20124341–21822609127
   PubMedGoogle Scholar
• JungJParkSJChungHKPolymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancerInt J Radiat Oncol Biol Phys2012841e77e8322795728
   PubMed Web of Science ®Google Scholar
• ChoiJKimHYJuEJUse of macrophages to deliver therapeutic and imaging contrast agents to tumorsBiomaterials201233164195420322398206
   PubMed Web of Science ®Google Scholar
• ChoiJWooH-NJuEJImmunocytes as a biocarrier to delivery therapeutic and imaging contrast agents to tumorsJ Nanomater. 20122012 Available from: http://dx.doi.org/10.1155/2012/863704Accessed September 4, 2015
   Google Scholar
• WoolfeGMacdonaldADThe evaluation of the analgesic action of pethidine hydrochloride (Demerol)J Pharmacol Exp Ther1944803300307
   Google Scholar
• BianchiRBuyukakilliBBrinesMErythropoietin both protects from and reverses experimental diabetic neuropathyProc Natl Acad Sci U S A2004101382382814718663
   PubMed Web of Science ®Google Scholar
• WangYXBowersoxSSPettusMGaoDAntinociceptive properties of fenfluramine, a serotonin reuptake inhibitor, in a rat model of neuropathyJ Pharmacol Exp Ther199929131008101610565818
   PubMed Web of Science ®Google Scholar
• PatilCRGadekarARPatelPNRambhadeASuranaSJGaushalMHDual effect of Toxicodendron pubescens on carrageenan induced paw edema in ratsHomeopathy2009982889119358961
   PubMed Web of Science ®Google Scholar
• TaurinSNehoffHGreishKAnticancer nanomedicine and tumor vascular permeability; where is the missing link?J Control Release2012164326527522800576
   PubMed Web of Science ®Google Scholar
• FangJNakamuraHMaedaHThe EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Deliv Rev201163313615120441782
   PubMed Web of Science ®Google Scholar
• GreishKEnhanced permeability and retention of macromolecular drugs in solid tumors: a reoal gate targeted anticancer nanomedicinesJ Drug Target2007157–845746417671892
   PubMed Web of Science ®Google Scholar
• KudlowitzDMuggiaFDefining risks of taxane neuropathy: insights from randomized clinical trialsClin Cancer Res201319174570457723817688
   PubMed Web of Science ®Google Scholar
• GelmonKThe taxoids: paclitaxel and docetaxelLancet19943448932126712727967989
   PubMed Web of Science ®Google Scholar
• ParvathySSMasochaWMatrix metalloproteinase inhibitor COL-3 prevents the development of paclitaxel-induced hyperalgesia in miceMed Princ Pract2013221354122907189
   PubMed Web of Science ®Google Scholar
• RoglioIBianchiRCamozziFDocetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental modelJ Peripher Nerv Syst2009141364419335538
   PubMed Web of Science ®Google Scholar
• ParkSBKrishnanAVLinCSGoldsteinDFriedlanderMKiernanMCMechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategiesCurr Med Chem200815293081309419075655
   PubMed Web of Science ®Google Scholar
• OhsumiSShimozumaKOhashiYSubjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: the National Surgical Adjuvant Study of Breast Cancer 02Oncology201282313113822433221
   PubMed Web of Science ®Google Scholar
• BronstadABergAReedRKEffects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressureAm J Physiol Heart Circ Physiol20042872H963H96815059777
   PubMed Web of Science ®Google Scholar
• De JongWHHagensWIKrystekPBurgerMCSipsAJGeertsmaREParticle size-dependent organ distribution of gold nanoparticles after intravenous administrationBiomaterials200829121912191918242692
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• KumarRRoyIOhulchanskkyTYIn vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticlesACS Nano20104269970820088598
   PubMed Web of Science ®Google Scholar